80 related articles for article (PubMed ID: 9448706)
1. Cytotoxicity and subcellular localization of boronated phenanthridinium analogues.
Gedda L; Silvander M; Sjöberg S; Tjarks W; Carlsson J
Anticancer Drug Des; 1997 Dec; 12(8):671-85. PubMed ID: 9448706
[TBL] [Abstract][Full Text] [Related]
2. The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids.
Gedda L; Ghaneolhosseini H; Nilsson P; Nyholm K; Pettersson J; Sjöberg S; Carlsson J
Anticancer Drug Des; 2000 Aug; 15(4):277-86. PubMed ID: 11200503
[TBL] [Abstract][Full Text] [Related]
3. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy.
Yong JH; Barth RF; Rotaru JH; Wyzlic IM; Soloway AH
Anticancer Res; 1995; 15(5B):2039-43. PubMed ID: 8572599
[TBL] [Abstract][Full Text] [Related]
5. Dynamic SIMS ion microscopy imaging of intracellular boron accumulation from carboranyl nucleosides in glioma cells.
Gay I; Lorey DR; Schinazi RF; Morrison GH; Chandra S
Anticancer Res; 2001; 21(4A):2369-75. PubMed ID: 11724295
[TBL] [Abstract][Full Text] [Related]
6. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors.
Zhuo JC; Cai J; Soloway AH; Barth RF; Adams DM; Ji W; Tjarks W
J Med Chem; 1999 Apr; 42(7):1282-92. PubMed ID: 10197971
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cellular uptake and animal toxicity of a tetra(carboranylphenyl)-tetrabenzoporphyrin.
Gottumukkala V; Ongayi O; Baker DG; Lomax LG; Vicente MG
Bioorg Med Chem; 2006 Mar; 14(6):1871-9. PubMed ID: 16298134
[TBL] [Abstract][Full Text] [Related]
9. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
11. Positive cooperativity in the cellular uptake of a boronated porphyrin.
Novick S; Laster B; Quastel MR
Int J Biochem Cell Biol; 2006; 38(8):1374-81. PubMed ID: 16616577
[TBL] [Abstract][Full Text] [Related]
12. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels.
Callahan DE; Forte TM; Afzal SM; Deen DF; Kahl SB; Bjornstad KA; Bauer WF; Blakely EA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):761-71. PubMed ID: 10524433
[TBL] [Abstract][Full Text] [Related]
13. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
[TBL] [Abstract][Full Text] [Related]
14. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
16. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
[TBL] [Abstract][Full Text] [Related]
19. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates.
Leśnikowski ZJ; Paradowska E; Olejniczak AB; Studzińska M; Seekamp P; Schüssler U; Gabel D; Schinazi RF; Plesek J
Bioorg Med Chem; 2005 Jul; 13(13):4168-75. PubMed ID: 15878666
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of boron and boronated compounds.
Benderdour M; Bui-Van T; Dicko A; Belleville F
J Trace Elem Med Biol; 1998 Mar; 12(1):2-7. PubMed ID: 9638606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
